ENHANCED SYNTHESIS OF EPOXYEICOSATRIENOIC ACIDS BY CHOLESTEROL-FED RABBIT AORTA

被引:97
作者
PFISTER, SL
FALCK, JR
CAMPBELL, WB
机构
[1] UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,5323 HARRY HINES BLVD,DALLAS,TX 75235
[2] UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1991年 / 261卷 / 03期
关键词
ARACHIDONIC ACID; CYTOCHROME-P-450; 6-KETOPROSTAGLANDIN-F-1-ALPHA; ATHEROSCLEROSIS;
D O I
10.1152/ajpheart.1991.261.3.H843
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Arachidonic acid metabolism via cyclooxygenase, lipoxygenase, and cytochrome P-450 epoxygenase was investigated in thoracic aortic tissue obtained from rabbits fed either standard rabbit chow or chow containing 2% cholesterol. Aortic strips were incubated with [C-14]arachidonic acid and A23187. Metabolites from extracted media were resolved by high-pressure liquid chromatography (HPLC). Normal and cholesterol-fed rabbit aortas synthesized prostaglandins (PGs) and hydroxyeicosatetraenoic acids (HETEs). The major cyclooxygenase products were 6-keto-PGF1-alpha and PGE2. Basal aortic 6-keto-PGF1-alpha production was slightly reduced in cholesterol-fed compared with normal rabbits. 12(S)- and 15(S)-HETE were the major aortic lipoxygenase products from both normal and cholesterol-fed rabbits. The structures were confirmed by gas chromatography-mass spectrometry (GCMS). Only cholesterol-fed rabbit aortas metabolized arachidonic acid via cytochrome P-450 epoxygenase to the epoxyeicosatrienoic acids (EETs). 14,15-, 11,12-, 8,9-, and 5,6-EET were identified based on comigration on HPLC with known C-14-labeled standards and typical mass spectra. Incubation of normal aorta with 14,15-EET decreased the basal synthesis of 6-keto-PGF1-alpha. The other EETs were without effect. The four EET regioisomers relaxed the norepinephrine-precontracted normal and cholesterol-fed rabbit aorta. The relaxation response to 14,15-EET was greater in aortas from cholesterol-fed rabbits. These studies demonstrate that hypercholesterolemia, before the development of atherosclerosis, alters arachidonic acid metabolism via both the cyclooxygenase and epoxygenase pathways.
引用
收藏
页码:H843 / H852
页数:10
相关论文
共 37 条
[1]   CONVERSION OF ARACHIDONIC-ACID TO 2 NOVEL PRODUCTS BY A CYTOCHROME-P450-DEPENDENT MIXED-FUNCTION OXIDASE IN POLYMORPHONUCLEAR LEUKOCYTES [J].
BEDNAR, MM ;
SCHWARTZMAN, M ;
IBRAHAM, NG ;
MCGIFF, JC ;
MULLANE, KM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (02) :581-588
[2]   BIPHASIC RESPONSE OF INTIMAL PROSTACYCLIN PRODUCTION DURING THE DEVELOPMENT OF EXPERIMENTAL ATHEROSCLEROSIS [J].
BEETENS, JR ;
COENE, MC ;
VERHEYEN, A ;
ZONNEKEYN, L ;
HERMAN, AG .
PROSTAGLANDINS, 1986, 32 (03) :319-334
[3]   EFFECTS OF HYPERCHOLESTEROLEMIC PLASMA ON VASCULAR SENSITIVITY TO NORADRENALINE [J].
BLOOM, D ;
MCCALDEN, TA ;
ROSENDORFF, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 54 (04) :421-427
[4]   CELLULAR PATHOLOGY OF PROGRESSIVE ATHEROSCLEROSIS IN THE WHHL RABBIT - AN ANIMAL-MODEL OF FAMILIAL HYPERCHOLESTEROLEMIA [J].
BUJA, LM ;
KITA, T ;
GOLDSTEIN, JL ;
WATANABE, Y ;
BROWN, MS .
ARTERIOSCLEROSIS, 1983, 3 (01) :87-101
[5]   VASOACTIVITY OF ARACHIDONIC-ACID EPOXIDES [J].
CARROLL, MA ;
SCHWARTZMAN, M ;
CAPDEVILA, J ;
FALCK, JR ;
MCGIFF, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 138 (02) :281-283
[6]   SELECTIVE EPOXIDATION OF EICOSA-CIS-5,8,11,14-TETRAENOIC (ARACHIDONIC) ACID AND EICOSA-CIS-8,11,14-TRIENOIC ACID [J].
COREY, EJ ;
NIWA, H ;
FALCK, JR .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1979, 101 (06) :1586-1587
[7]   THE VASODILATATION INDUCED BY HYDROPEROXY METABOLITES OF ARACHIDONIC-ACID IN THE RAT MESENTERIC AND PULMONARY CIRCULATION [J].
DALARCAO, M ;
COREY, EJ ;
CUNARD, C ;
RAMWELL, P ;
UOTILA, P ;
VARGAS, R ;
WROBLEWSKA, B .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 91 (03) :627-632
[8]   GENERATION OF PROSTACYCLIN BY ARTERIES AND BY CORONARY VASCULAR BED IS REDUCED IN EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS [J].
DEMBINSKAKIEC, A ;
GRYGLEWSKA, T ;
ZMUDA, A ;
GRYGLEWSKI, RJ .
PROSTAGLANDINS, 1977, 14 (06) :1025-1034
[9]  
FITZPATRICK FA, 1986, J BIOL CHEM, V261, P5334
[10]  
FITZPATRICK FA, 1989, PHARMACOL REV, V40, P229